Terms: = Endocrine gland cancer AND ETV4, PEA3, 2118, ENSG00000175832, E1AF, E1A-F, PEAS3 AND Prognosis
8 results:
1. Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic cancer.
Zhou Z; Ren Y; Yang J; Liu M; Shi X; Luo W; Fung KM; Xu C; Bronze MS; Zhang Y; Houchen CW; Li M
Gastroenterology; 2022 Nov; 163(5):1281-1293.e1. PubMed ID: 35777482
[TBL] [Abstract] [Full Text] [Related]
2. Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry.
Nabeta R; Katselis GS; Chumala P; Dickinson R; Fernandez NJ; Meachem MD
Vet Comp Oncol; 2022 Sep; 20(3):720-731. PubMed ID: 35514180
[TBL] [Abstract] [Full Text] [Related]
3. Papillary thyroid cancer: the value of bilateral diagnostic lymphadenectomy.
Bhangu JS; Bichler C; Altmeier J; Hargitai L; Selberherr A; Mazal P; Brugger J; Scheuba C; Riss P; Niederle B
Langenbecks Arch Surg; 2022 Aug; 407(5):2059-2066. PubMed ID: 35301585
[TBL] [Abstract] [Full Text] [Related]
4. Impact of Capicua on Pancreatic cancer Progression.
Yoshiya S; Itoh S; Yoshizumi T; Yugawa K; Kurihara T; Toshima T; Harada N; Hashisako M; Yonemasu H; Fukuzawa K; Oda Y; Mori M
Ann Surg Oncol; 2021 Jun; 28(6):3198-3207. PubMed ID: 33216264
[TBL] [Abstract] [Full Text] [Related]
5. CRLF1-MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/etv4 Axis.
Yu ST; Sun BH; Ge JN; Shi JL; Zhu MS; Wei ZG; Li TT; Zhang ZC; Chen WS; Lei ST
Front Endocrinol (Lausanne); 2020; 11():535. PubMed ID: 32982961
[TBL] [Abstract] [Full Text] [Related]
6. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
[TBL] [Abstract] [Full Text] [Related]
7. Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy.
Barrett CL; DeBoever C; Jepsen K; Saenz CC; Carson DA; Frazer KA
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3050-7. PubMed ID: 26015570
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.
Menendez JA; Vellon L; Mehmi I; Oza BP; Ropero S; Colomer R; Lupu R
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10715-20. PubMed ID: 15235125
[TBL] [Abstract] [Full Text] [Related]
